The Pap test (sometimes called a Pap smear) is a way to examine cells collected from the cervix and vagina. This test can show the presence of infection, abnormal cells, or cancer. Pap smears and/or pelvic examinations are considered "screening" when performed for women who have neither symptoms nor signs of disease. A screening pelvic examination with or without specimen collection for smears and cultures, should include at least seven of the following eleven elements:
Indications and Limitations of Coverage Screening Pap Smears (G0123, G0124, G0141, G0143, G0144, G0145, G0147, G0148, P3000, P3001, Q0091) Payment may be made for a screening pap smear according to approved frequency schedules. Screening Pap smears are covered when ordered and collected by a doctor of medicine or osteopathy or other authorized practitioner (e.g., a certified nurse midwife, physician assistant, nurse practitioner, or clinical nurse specialist, who is authorized under state law to perform the examination).
Screening Pelvic Examination (G0101, S0610, S0612) (including a clinical breast exam, S0613) Members are entitled to one routine exam each calendar year. A screening Pap smear or screening pelvic examination performed for women who do not meet the criteria outlined in the "Indications and Limitations of Coverage" section of this policy will be denied. A covered evaluation and management visit and code Q0091 may be reported by the same physician for the same date of service if the evaluation and management visit is for a separately identifiable service. In this case, the 25 modifier must be reported with the evaluation and management service and the medical records must clearly document the evaluation and management service reported. When code Q0091 is reported on the same day by the same physician as an evaluation and management service, combine the charges and pay only the evaluation and managenet service. Payment for the evaluation and management service performed on the same date of service includes the allowance for Q0091. A provider cannot bill the member separately for Q0091 in this case. A covered evaluation and management visit and codes G0101, S0610, or S0612 may be reported by the same physician for the same date of service if the evaluation and management visit is for a separately identifiable service. In this case, the 25 modifier must be reported with the evaluation and management service and the medical records must clearly document the evaluation and management service reported.
Cervical and vaginal smears do not require interpretation by a physician unless the results are, or appear to be, abnormal. In such cases, a physician personally conducts a separate microscopic evaluation to determine the nature of an abnormality. Separate payment is allowed for patients in any setting if the laboratory's screening personnel suspect an abnormality and the physician reviews and interprets the Pap smear. This physician service should be reported using code G0124, G0141, or P3001, as appropriate. Diagnosis code V76.49 (Special screening for malignant neoplasms, other sites) should be used when reporting a screening pelvic examination for an asymptomatic woman who does not have a uterus or cervix. A screening Pap smear and a screening pelvic examination can be performed during the same encounter. When this happens, both procedure codes should be shown as separate line items on the claim. These services can also be performed separately during separate office visits.
Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations. Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury. Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim. CMS Internet On-Line Manual, Pub. 100-3, Chapter 1, Section 210.2. CMS Internet On-Line Manual, Pub. 100-4, Chapter 12, Section 60, Chapter 18, Sections 30, 40. Program Memorandum B-97-15, CR #168 Program Memorandum B-98-16, CR #452 Transmittal 1675, CR 1254 Transmittal 1694, CR 1497 Transmittal AB-03-054, CR 2637 Transmittal 440, CR 3659 Transmittal 1541, CR 6085
One or more of the following diagnosis codes apply to screening pelvic exams and screening Pap smears.
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records. Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern. Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Medicare Advantage plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions. Medicare Advantage retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Medicare Advantage. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use. |